Ratings by Citizens (Daniel Stauder)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/3/2026 | Stereotaxis | STXS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/8/2026 | Artivion Inc. | AORT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/6/2026 | LeMaitre Vascular | LMAT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/1/2026 | Stereotaxis | STXS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/26/2026 | LeMaitre Vascular | LMAT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/25/2026 | Avanos Medical | AVNS | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 2/20/2026 | LeMaitre Vascular | LMAT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/18/2026 | AtriCure Inc. | ATRC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/12/2026 | AtriCure Inc. | ATRC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/4/2026 | Avanos Medical | AVNS | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 11/7/2025 | Artivion Inc. | AORT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/30/2025 | AtriCure Inc. | ATRC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/10/2025 | Artivion Inc. | AORT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/8/2025 | Artivion Inc. | AORT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/30/2025 | AtriCure Inc. | ATRC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/28/2025 | LeMaitre Vascular | LMAT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/28/2025 | Artivion Inc. | AORT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/6/2025 | Artivion Inc. | AORT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/30/2025 | AtriCure Inc. | ATRC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/2/2025 | AtriCure Inc. | ATRC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/28/2025 | LeMaitre Vascular | LMAT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/25/2025 | Artivion Inc. | AORT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/13/2025 | AtriCure Inc. | ATRC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/10/2025 | AtriCure Inc. | ATRC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/23/2024 | Artivion Inc. | AORT | New Coverage | Market Outperform (N/A) |
26.64 (20.34) |
-23.65% | Details | |
| 8/20/2024 | LeMaitre Vascular | LMAT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/28/2024 | LeMaitre Vascular | LMAT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/23/2023 | LeMaitre Vascular | LMAT | New Coverage | Market Outperform (N/A) |
48.16 (91.61) |
90.22% | Details | |
| 10/23/2023 | AtriCure Inc. | ATRC | New Coverage | Market Outperform (N/A) |
35.29 (28.63) |
-18.87% | Details |
